Factors influencing the quality of life of lymphoma patients Surat Thani hospital
Article Sidebar
Main Article Content
Abstract
This study is a cross-sectional analysis, study aimed to the quality of life of patients’ lymphoma, and to investigate the factors predicting the quality of life of lymphoma patients in Surat Thani Hospital. The sample group was patients diagnosed with lymphoma, aged 18 years and over, who consented to cooperate in answering the questionnaire. Exclusion criteria were that patients were unable to communicate and understand. The sample size was calculated using the G*Power program with a total of 150 subjects. The sample was random sampling, picking labels. The tools are personal data recording form and quality of life measure, the functional assessment of cancer therapy-general version 4, Thai version (FACT - G). Check the validity, CVI was 0.96, 0.89, respectively. The reliability was equal to 0.87, 0.90, respectively. The power of prediction was analyzed using multiple linear regression.
The results found that lymphoma patients had a moderate quality of life, 73.4 %, and complications after received chemotherapy and cancer type were factor that influence predicting the quality of life of lymphoma patients at 33.2 % (R2=.332) and complications after receiving chemotherapy (β=-.557) had a higher influence on the quality of life than the type of cancer. (β =-.141) with statistical significance P<.05
Summary of research results, the quality of life of patients’ lymphoma most is moderate. Complication after receiving chemotherapy and the type of cancer influences quality of life and it was found that the symptoms of complications that occurred after receiving chemotherapy were hair loss, fatigue, and changes in taste and smell, decreased appetite, nausea, vomiting, constipation, and mouth ulcers.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Borel C, Lamy S, Compaci G, Récher C, Jeanneau P, Nogaro JC, Bauvin E, Despas F, Delpierre C, Laurent G. A. (2015). longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival. BMC Cancer, 15, 288. doi: 10.1186/s12885-015-1287-9
Jensen, R.E., Arora, N.K., Bellizzi, K.M., Rowland, J.H., Hamilton, A.S., Aziz, N.M. (2013). Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer, 119(3), 672–680.
Kang, D., Cho, J., Kim, I.R., Kim, M.K., Kim, W.S., Kim, S.J. (2018). Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study. Cancer Research and Treatment, 50(4), 1051-1063.
kanya, P., Sirijanchune, P. and Chueamuangphan, N. (2021). Overall Survival and Risk Factors of Relapsed or Refractory of The Treatment of Diffuse Large B-Cell Lymphoma in Chiangrai Prachanukroh Hospital. Chiangrai Medical Journal, 12(1), 1-12.
Kim, B.J., Park, H.R., Roh, H.J., Jeong, D.S., Kim, B.S., Park K.W., Cho, S.C., So, Y.T., Oh, S.J., Kim, S.J. (2010). Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma. Quality of Life Research, 19(8), 1097-103.
Klastersky. J., Naurois D.J., Rolston, K., Rapoport, B., Maschmeyer, G., Aapro, M., et al. (2016). Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annals of Oncology, 27(5), 111-118.
Oerlemans, S., Mols, F., Nijziel, M.R., Lybeert, M., van de Poll-Franse, L.V. (2011). The impact of treatment, sociodemographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review. Annals of Hematology, 90(9), 993-1004.
Sathaporn, T., Chinvararak, C. and Bunworasate, U. (2021). Quality of life and associated factors of lymphoma patients in Hematology Clinic at King Chulalongkorn Memorial Hospital. Chulalongkorn Medical Journal, 3(1), 11-21.
Soares, A., Biasoli, I., Scheliga, A., Baptista, R.L., Brabo, E.P., Morais, J.C. (2013). Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma. Support Care Cancer, 21(8), 2153-2159.
Wasse, S.K., Mounier, M., Assogba, E., Rossi, C., Adnet, J., Gauthier, S., Girard, S., Atsou, K.M., Dabakuyo-Yonli, T.S. and Maynadie, M. (2023). Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study. Cancers (Basel), 15(15), 3885.
Yoobang, N. (2022). Outcome and Prognostic Factors in Diffuse Large B-cell Lymphoma Patients in Mahasarakham Hospital. Mahasarakham hospital Journal, 20(1), 80-96.